Effect of Ozoralizumab Administration with or without Methotrexate in Patients with Rheumatoid Arthritis: A Post-Hoc Analysis
OZR administration without MTX was associated with an improvement in the signs and symptoms of RA compared to placebo administration (continuation of MTX monotherapy). OZR and MTX administration showed better efficacy than OZR administration alone.
Authors
- Masafumi Kawanishi (ORCID: https://orcid.org/0000-0003-4104-8548)
- Yoshiya Tanaka (ORCID: https://orcid.org/0000-0002-0807-7139)
- Nobuko Horiuchi
- Rumiko Matsumoto
- Tsutomu Takeuchi (ORCID: https://orcid.org/0000-0003-1111-8218)
- Saeko Uchida
- Cosmo Sasajima
Institutions
- Taisho Pharmaceutical (Japan) (JP)
- University of Occupational and Environmental Health Japan (JP)
- Keio University Hospital (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1007/s40744-024-00737-3
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- Sanofi
- Ablynx
- Taisho Toyama Pharmaceutical Company